{"url_path":"/sec/ueec/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-003228-index.html","accession_number":"0001477932-26-003228","cik":"0001096938","ticker":"UEEC","issuer_name":"United Health Products, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1096938/0001477932-26-003228-index.html","primary_entity_key":"0001096938","primary_entity_name":"United Health Products, Inc."},"word_count":46,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n \n\nDuring the quarter ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” as each term is defined in Item 408(a) of Regulation S-K.\n\n \n\n \n\n26\n\n*Table of Contents*"}